A comprehensive view of argenx SE. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
FUJIFILM Diosynth Biotechnologies expands manufacturing agreement with argenx for the production of the autoimmune disease drug efgartigimod; the deal builds upon a previous agreement announced in October 2022
Published:
March 25, 2024
by Fujifilm Corp.
|
Ask us about our Health Care Sector market view